logo
AI Icon𝛼SK or Search
ENTITY

Insilico Medicine (3696 HK)

69
Analysis
Health Care • Hong Kong
Insilico Medicine is an artificial intelligence (AI)-based biotechnology company that applies AI solutions to drug discovery and development, leveraging its proprietary Pharma.AI platform to identify and design early-stage drug candidates. The company develops novel drugs for various diseases, including cancer, fibrosis, immunity, and central nervous system disorders, and predicts clinical trial outcomes. Insilico Medicine was founded in 2014 and is headquartered in New Territories, Hong Kong.
more
Company Event • 25 Nov 2026 12:30 • Upcoming
Add To Calendar

Q3 2026

Company Event • 28 Aug 2026 21:00 • Upcoming
Add To Calendar

Q1 2026

Company Event • 26 Aug 2026 17:00 • Latest

Q2 2026

Company Event • 31 Jul 2026 12:30 • Upcoming
Add To Calendar

Q1 2026

Company Event • 01 May 2026 16:00 • Upcoming
Add To Calendar

Corporate presentation

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x